Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer
Conditions: Triple-negative Breast Cancer; Cadonilimab Interventions: Drug: Cadonilimab Sponsors: Wuhan Union Hospital, China Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | China Health | COVID-19 | Hospitals | Research